Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study.

Aldo MarroneRiccardo NevolaAusilia SellittoDomenico CozzolinoCiro RomanoGiovanna CuomoConcetta ApreaMichelangelo X Palou SchwartzbaumCarmen RicozziSimona ImbrianiLuca RinaldiKlodian GjeloshiAndrea PadulaRoberta RanieriCarolina RuosiLuciana Agnese MeoMarianna AbitabileFrancesca CinoneCaterina CarusoneLuigi Elio Adinolfi

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Remdesivir/dexamethasone treatment is associated with significant reduction in mortality, length of hospitalization, and faster SARS-CoV-2 clearance, compared to dexamethasone alone.

Keyphrases

sars cov
high dose
low dose
coronavirus disease
respiratory syndrome coronavirus
stem cells
combination therapy
risk factors
bone marrow
coronary artery disease